arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Annexon, Inc.

ANNX
$5.39 ▼ -0.21 (-3.75%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
30 Visible periods
18 Metrics
Peer-ranked Benchmarks
Price Chart
24
Health
Poor
Bearish
auto_awesome

Analytical Summary

Annexon, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.0B
Dividend Yield
Revenue Growth
Op. Margin
ROIC -17.8%
FCF / Share $-0.24
Trailing P/E
Price / Book 5.1x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

30-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-44.14M
↑ +18.8%
FCF / Share Free cash flow per share
$-0.24
↑ +28.8%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
9
Cash Quality
60

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 30 quarters